NEWS
Advancements in Patient-Centered Care
Stay up to date with the latest advancements in oral oncolytics, medically-integrated oncology, and cancer care best practices.
Use of Rucaparib (Rubraca®) In the Treatment of Ovarian, Fallopian Tube, Primary Peritoneal or Prostate Cancer
September 7, 2021
Enzalutamide (Xtandi®) for patients with castration-resistant prostate cancer or metastatic castration-sensitive prostate cancer
September 7, 2021
Trilaciclib (Cosela™) Management
September 7, 2021
Lurbinectedin (ZepzelcaTM) for Small Cell Lung Cancer
September 3, 2021
NCODA Expands Patient and Caregiver Resource to Improve Understanding and Outcomes
September 1, 2021
Netupitant/Fosnetupitant and Palonosetron (Akynzeo®) for Chemotherapy-Induced Nausea and Vomiting
August 11, 2021
NCODA Structures Medically Integrated Pharmacy Accreditation
August 10, 2021
BIDEN ADMINISTRATION PROPOSES WITHDRAW FROM MOST FAVORED NATION
August 9, 2021
Florida Cancer Specialists & Research Institute to mandate COVID-19 vaccines for its workforce
August 9, 2021
Tafasitamab-cxix (Monjuvi®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
August 5, 2021
FDA Approves Dose Escalation Label Update for Puma Biotechnology’s NERLYNX® (neratinib) in HER2-Positive Early Stage and Metastatic Breast Cancer
August 2, 2021
Epizyme Launches EZH2Now Testing Program with Quest Diagnostics for Relapsed or Refractory Follicular Lymphoma Patients
July 27, 2021
RESOURCES
Cost Avoidance Waste Tracker
PQI in Action
OCE Sheets
IVE Sheets
Treatment Support Kits
PQI Podcast
Members
Member Resources
OPTA
Committees
Member Login
Events
Webinars
Spring Forum
Oncology Institute
PSO Annual Meeting
Fall Summit
315-655-4640
P.O. Box 468
Cazenovia, NY 13035
NURSE RESOURCES
Through collaboration between oncology nurses throughout North America, these resources are available to all NCODA members.